Isoquercitrin Improves Insulin Resistance by Inhibiting PTP1B-Regulated IRS/PI3K/AKT Signaling PathwayOA
Isoquercitrin Improves Insulin Resistance by Inhibiting PTP1B-Regulated IRS/PI3K/AKT Signaling Pathway
LIU Si-yu;YU Lu-jing;ZHANG Sheng-nan;YUE Jia-kui;JIANG Guo-jun;LU Si-hua;LI Ying-jia;MENG Jun-yu;HUANG Gui-hong
Department of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||School of Pharmacy,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||Department of Pharmacy,Heilongjiang Provincial Hospital,Harbin(150000),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||School of Pharmacy,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||School of Pharmacy,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||School of Pharmacy,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||School of Pharmacy,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),ChinaDepartment of Pharmacy,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders||Key Laboratory of Diabetic Systems Medicine,the Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China||Guangxi Key Laboratory of Drug Discovery and Optimization||Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation,School of Pharmacy,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region(541199),China
insulin resistanceisoquercitrinChinese medicineprotein tyrosine phosphatase 1Binsulin receptor substrate/phosphatidylinositol-3-kinase/protein kinase B signal pathway
insulin resistanceisoquercitrinChinese medicineprotein tyrosine phosphatase 1Binsulin receptor substrate/phosphatidylinositol-3-kinase/protein kinase B signal pathway
《中国结合医学杂志（英文版）》 2026 (4)
340-349,10
Supported by National Natural Science Foundation of China(No.82160701)Guangxi Natural Science Foundation(No.2025GXNSFAA069059)Medical Science Research Fund of Beijing Health Alliance Charitable Foundation(No.KM226002)and Guilin Medical University Master's Research Project(No.GYYK2022004)
评论